Determination of ficolin-2 concentration in cord serum may be considered a new early prognostic factor in RDS development, helpful to distinguish RDS from other prematurity-associated respiratory disorders and thus facilitating the choice of appropriate treatment. The gene discussed is FCN2; the disease is newborn respiratory distress syndrome.